Ollier Michele
Related Filers (2)
Other (9)
13F-NT
Thursday, 2/3/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Wednesday, 11/10/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 8/3/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 5/11/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 2/12/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 10/27/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Friday, 8/7/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 5/12/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/11/2020
Initial Quarterly Form 13F Notice Report filed by institutional managers
Ownership (10)
4
Wednesday, 12/14/2016
Minerva Neurosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/12/2016
Minerva Neurosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/20/2015
Minerva Neurosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/9/2014
Minerva Neurosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 6/30/2014
Minerva Neurosciences, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 8/2/2011
Aegerion Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/1/2011
Aegerion Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2011
Aegerion Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/27/2010
Aegerion Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 10/22/2010
Aegerion Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities